Literature DB >> 20129022

Severe renal failure and microangiopathic hemolysis induced by malignant hypertension--case series and review of literature.

L Shavit1, C Reinus, I Slotki.   

Abstract

Malignant nephrosclerosis is acute renal failure in the setting of malignant hypertension and may be associated with thrombotic microangiopathy. Although the prognosis has improved considerably over the past decades, renal dysfunction remains an important cause of morbidity and mortality. Adequate control of blood pressure is crucial, allows gradual healing of the necrotizing vascular lesions and may induce stabilization and improvement of renal function in about 50 - 80% of involved patients. In addition, recent investigations have provided a better understanding of the pathophysiology of malignant hypertension and offer possibilities for identifying patients at risk. We report 3 patients who developed severe acute renal failure requiring dialysis initiation in the setting of malignant hypertension. All patients had kidney biopsy proven malignant nephrosclerosis and presented with symptoms of thrombotic microangiopathy. Despite adequate blood pressure control the prognosis of our patients varied.

Entities:  

Mesh:

Year:  2010        PMID: 20129022     DOI: 10.5414/cnp73147

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura.

Authors:  Nabin Khanal; Sumit Dahal; Smrity Upadhyay; Vijaya Raj Bhatt; Philip J Bierman
Journal:  Ther Adv Hematol       Date:  2015-06

Review 2.  Thrombotic Microangiopathy and the Kidney.

Authors:  Vicky Brocklebank; Katrina M Wood; David Kavanagh
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

3.  Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy.

Authors:  Christopher P Larsen; Jon D Wilson; Alejandro Best-Rocha; Marjorie L Beggs; Randolph A Hennigar
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

4.  Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study.

Authors:  Satish Haridasan; P S Priyamvada; Dhanin Puthiyottil; Arjun Pradeep; Sreejith Parameswaran; B H Srinivas; Rajesh Nachiappa Ganesh
Journal:  Indian J Nephrol       Date:  2021-04-10

5.  Thrombotic Microangiopathy Due to Malignant Hypertension Treated Exclusively With Antihypertensive Therapy.

Authors:  Taro Asano; Hideki Mori
Journal:  Cureus       Date:  2022-02-02

6.  Malignant hypertension: does this still exist?

Authors:  Magdalena Domek; Jakub Gumprecht; Gregory Y H Lip; Alena Shantsila
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

7.  Emergency management of hypertension in children.

Authors:  Dinesh Singh; Olugbenga Akingbola; Ihor Yosypiv; Samir El-Dahr
Journal:  Int J Nephrol       Date:  2012-04-19

8.  A case report of malignant hypertension in a young woman.

Authors:  Andrea Michelli; Stella Bernardi; Andrea Grillo; Emiliano Panizon; Matteo Rovina; Moreno Bardelli; Renzo Carretta; Bruno Fabris
Journal:  BMC Nephrol       Date:  2016-07-07       Impact factor: 2.388

9.  Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Authors:  Vicky Brocklebank; David Kavanagh
Journal:  Clin Kidney J       Date:  2017-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.